Clinical Trial Application

Related by string. * clinicals . CLINICAL . Clinicals : Phase III clinical trials . Phase III clinical . placebo controlled clinical trials / trialed . trialing . trials : Week Premium Trial . Phase III trials . randomized controlled trial / applications . Applications . application : Application Delivery Networking . Oracle Application Server . Application Programming Interface API * *

Related by context. Frequent words. (Click for all words.) 66 Marketing Authorization Application 64 Biologics License Application 63 Marketing Authorization Application MAA 63 Pivotal Phase III 62 Investigational Device Exemption 62 Phase III Clinical Trial 61 Marketing Authorization 60 Icatibant 60 Swissmedic 60 Biologics License Application BLA 60 Ceftobiprole 59 Orphan Drug Status 59 orphan designation 59 Orphan Drug status 59 Mutual Recognition Procedure 58 Orphan Drug designation 58 Investigational 58 BLA submission 57 supplemental Biologics License Application 57 Investigational Device Exemption IDE 57 New Drug Application 57 Therapeutic Products 57 sNDA 57 IND submission 57 sBLA 56 confirmatory Phase III 56 BEMA Fentanyl 56 Phase 1b clinical 56 IND 56 MONOVISC 56 phase IIa 56 pharmacokinetic studies 55 Pivotal Trial 55 Phase IIa trial 55 Drug Application 55 Complete Response 55 European Medicines Evaluation 55 Ceplene R 55 Phase IIb clinical 55 pivotal Phase III 55 Receives FDA Clearance 55 Phase III Trial 55 Drug Candidate 55 taliglucerase alfa 54 Toctino ® 54 New Drug IND 54 OTCQX RHHBY 54 Onsolis 54 ROTATEQ 54 FIRAZYR 54 Phase III clinical 54 Completes Enrollment 54 Abstral 54 Welfare MHLW 54 bazedoxifene 54 NOXAFIL 54 Clinical Study 54 Fast Track Designation 54 Act PDUFA date 54 Rhucin ® 54 Pirfenidone 53 Phase Ib 53 Clinical Trial Results 53 methylnaltrexone 53 Amrubicin 53 TORISEL 53 Extended Release Tablets 53 Initiates Phase 53 IMVAMUNE R 53 silodosin 53 ELND# 53 THELIN 53 PREOS 53 ATryn ® 53 Cimzia ® 53 Phase IIb trial 53 orphan medicinal product 53 FDA Clears 53 Orphan Drug Designation 53 Phase IIb 53 cervical cancer vaccine Cervarix 52 FDA Approves 52 FDA Approval 52 Rifaximin 52 Phase Ia 52 FDA Clearance 52 INDs 52 REPLAGAL 52 LIALDA 52 Nimotuzumab 52 Phase III clinical trials 52 NDA submission 52 registrational 52 investigational compound 52 Esbriet 52 Phase IIa 52 CHMP opinion 52 Phase 1b trial 52 Promacta 52 Phase 2b trial 52 voclosporin

Back to home page